359090 — C&R Research Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for C&R Research, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	7 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-19.3	—	3,928	5,560	3,359
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	-9.29	—	960	794	915
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	0.076	1,566	-3,012	-3,964	-2,708
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-28.5	2,249	2,523	3,512	2,839
Capital Expenditures	—	-1,281	-1,258	-219	-809
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-14,700	14,772	-8,880	-1,578	2,491
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-14,700	13,491	-10,138	-1,797	1,682
Financing Cash Flow Items	1,006	—	-3.52	263	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	14,788	-919	-5,316	-959	231
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	59.1	14,821	-12,937	747	4,860